Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Esophageal Cancer Research and Treatment

TopicLeading institutions, researchers & key papers

This cluster of papers focuses on the diagnosis, treatment, and management of esophageal cancer, with an emphasis on preoperative chemoradiotherapy, surgery, chemoradiation, and endoscopic resection. It also covers topics such as Barrett's esophagus, neoadjuvant therapy, adenocarcinoma, meta-analyses, and epidemiological trends.

593
Works

How has Esophageal Cancer Research and Treatment's publication output changed over time?

ScholarIQpublication output · 2002–2021

Output declined67% over the shown period — from 3 works in 2002 to 1 in 2021.

3
1
1
1
1
2
2
1
1
1
2002200520082009201120122015201820202021

What are the most-cited papers on Esophageal Cancer Research and Treatment?

ScholarIQmost cited works
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
Pieter van Hagen, Maarten C.C.M. Hulshof, J. Jan B. van Lanschot, Ewout W. Steyerberg, Mark I. van Berge Henegouwen, Bas P. L. Wijnhoven, Dick J. Richel, Grard A. P. Nieuwenhuijzen, Geke A.P. Hospers, Johannes J. Bonenkamp, Miguel A. Cuesta, R.J.B. Blaisse, Olivier R. Busch, F.J.W. ten Kate, G.J. Creemers, C.J.A. Punt, John Theodorus Plukker, Henk M.W. Verheul, Ernst Jan Spillenaar Bilgen, Herman van Dekken, Maurice J.C. van der Sangen, Tom Rozema, Katharina Biermann, Jannet C. Beukema, Anna H.M. Piet, Caroline M. van Rij, Janny G. Reinders, H.W. Tilanus, Ate van der Gaast
New England Journal of Medicine. 20125,537 CitationsOPEN ACCESS
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
Joël Shapiro, J. Jan B. van Lanschot, Maarten C.C.M. Hulshof, Pieter van Hagen, Mark I. van Berge Henegouwen, Bas P. L. Wijnhoven, Hanneke W.M. van Laarhoven, Grard A. P. Nieuwenhuijzen, Geke A.P. Hospers, Johannes J. Bonenkamp, Miguel A. Cuesta, R.J.B. Blaisse, Olivier R. Busch, Fiebo J.W. ten Kate, Geert-Jan Creemers, Cornelis J.A. Punt, John Th. M. Plukker, Henk M.W. Verheul, Ernst Jan Spillenaar Bilgen, Herman van Dekken, Maurice J.C. van der Sangen, Tom Rozema, Katharina Biermann, Jannet C. Beukema, Anna H.M. Piet, Caroline M. van Rij, Janny G. Reinders, Hugo W. Tilanus, Ewout W. Steyerberg, Ate van der Gaast
The Lancet Oncology. 20152,588 Citations
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer
Ronan J. Kelly, Jaffer A. Ajani, Jarosław Kużdżał, Thomas Zander, Eric Van Cutsem, Guillaume Piessen, Guillermo Méndez, Josephine Feliciano, Satoru Motoyama, Astrid Lièvre, Hope E. Uronis, Elena Elimova, Cecile Grootscholten, Karen Geboes, Syed Zafar, Stephanie Snow, Andrew H. Ko, Kynan Feeney, Michael Schenker, Piotr Kocoń, Jenny Zhang, Lili Zhu, Ming Lei, Prianka Singh, Kaoru Kondo, James M. Cleary, Markus Moehler
New England Journal of Medicine. 20211,813 CitationsOPEN ACCESS
Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial
Surya S. A. Y. Biere, Mark I. van Berge Henegouwen, K. W. Maas, Luigi Bonavina, Camiel Rosman, Josep Roig García, Suzanne S. Gisbertz, Jean H. G. Klinkenbijl, Markus W. Hollmann, Elly SM de Lange, H. Jaap Bonjer, Donald L. van der Peet, Miguel A. Cuesta
The Lancet. 20121,728 Citations
Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018
Anne F. Peery, Seth D. Crockett, Caitlin C. Murphy, Jennifer L. Lund, Evan S. Dellon, J. Lucas Williams, Elizabeth T. Jensen, Nicholas J. Shaheen, A. Sidney Barritt, Sarah R. Lieber, Bharati Kochar, Edward L. Barnes, Yali Fan, Virginia Pate, Joseph Galanko, Todd H. Baron, Robert S. Sandler
Gastroenterology. 20181,665 CitationsOPEN ACCESS

Where is Esophageal Cancer Research and Treatment research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation
NIH
Wellcome Trust
European Research Council
Funder breakdown is a member featureSign up free to unlock

How much of the research on Esophageal Cancer Research and Treatment is open access?

ScholarIQopen access share
53%OPEN ACCESS
Gold
0%
Green
0%
Hybrid
0%
Bronze
53%
Closed
47%

Related on ScholarIQ

Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
Paper
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
Paper
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
Paper
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
Paper
Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer
Paper
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
Paper
470M+ articles · free account